BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 9870789)

  • 1. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
    Tuipae S; Yanaranop M; Oniem N
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
    Piver MS; Chung WS
    Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.